Aggarwal BB, Puri RK. Common and uncommon features of cytokines and cytokine receptors: an overview. In: Human Cytokines: Their Role in Disease and Therapy. Cambridge, MA: Blackwell Science; 1995:3-24.
Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest. 1993;91:759-765.
Clerici M, Shearer GM. A TH1 → TH2 switch is a critical step in the etiology of HIV infection. Today. 1993;14:107-110.
Cook EB, Stahl JL, Lowe L, et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs non-allergics. J Immmol Meth. 2001;254:109-118.
Croft M, Carter L, Swain S, Dutton RW. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting Type 2 versus Type 1 cytokine profiles. J Exp Med. 1994;180:1715-1728.
ElGhazali GEB, Paulie S, Andersson G, et al. Number of interleukin-4– and interferon- γ –secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur J Immunol. 1993;23:2740-2745.
Elson LH, Nutman TB, Metcalfe DD, Prussin C. Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+ CD27- lymphocyte subpopulation. J Immunol. 1995;154:4294-4301
Graves JD, Downward J, Izquierdo-Pastor M, Rayter S, Warne PH, Cantrell DA. The growth factor IL-2 activates p21ras proteins in normal human lymphocytes. J Immunol. 1992;148:2417-2422.
Graziosi C, Pantaleo G, Gantt KR, et al. Lack of evidence for the dichotomy of T H 1 and T H 2 predominance in HIV-infected individuals. Science. 1994;265:248-252.
Gusella GL, Musso T, Bosco MC, Expinoza-Delgado I, Matsushima K, Varesio L. IL-2 upregulates but IFN-γ suppresses IL-8 expression in human monocytes. J Immunol. 1993;151:2725-2732.
Hillman GG, Haas GP. Role of cytokines in lymphocyte functions. Human Cytokines: Their Role in Disease and Therapy. 1995:37-54.
Hyjek E, Lischner HW, Hyslop T, et al. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol. 1995;155:4060-4071.
Lanier LL, Benike CJ, Phillips JH, Engleman EG. Recombinant interleukin-2 enhanced natural killer cell– mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu-7 and Leu-11 antigens. J Immunol. 1985;134:794-801.
Maggi EM, M, Ravina A, Annunziato F, et al. Ability of HIV to promote a T H 1 to T H 0 shift and to replicate preferentially in TH2 and TH0 cells. Science. 1994;265:244-248.
Musso T, Espinoza-Dalgado I, Pullki K, Gusella G, Longo D, Varesio L. IL-2 induces IL-6 production in human monocytes. J Immunol. 1992;148:795-800.
Openshaw P, Murphy EE, Hosken NA, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med. 1995;182:1357-1367.
Phillips JH, Gemlo BT, Myers WW, Rayner AA, Lanier LL. In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy. J Clin Oncology. 1987;5:1933-1941.
Picker LJ, Singh MK, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood. 1995;86:1408-1419.
Röcken M, Müller KM, Saurat J-H, et al. Central role for TCR/CD3 ligation in the differentiation of CD4+ T cells toward a TH1 or TH2 functional phenotype. J Immunol. 1992;148:1031-1036.
Röcken M, Saurat J-H, Hauser C. A common precursor for CD4+ T cells producing IL-2 or IL-4. J Immunol. 1992;148:47-54.
Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 1991;5:171-176.
Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods. 1998;212:89-98.
Zhang X, Giangreco L, Broome E, Dargan CM, Swain SL. Control of CD4 effector fate: transforming growth factor β 1 and interleukin-2 synergize to prevent apoptosis and promote effector expansion. J Exp Med. 1995;182:669-709.